Erkang Pharmaceutical: Summary table of non-operating capital expenditure and other related capital transactions for the first half year of 2024
Hunan Er-kang Pharmaceutical: Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Er-kang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hunan Er-kang Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Erkang Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Erkang Pharmaceutical: Comparative Table of Amendments to the Articles of Association
Erkang Pharmaceuticals: Announcement on Launching Hedging Business
Erkang Pharmaceuticals: 2023 Internal Control Self-Evaluation Report
Erkang Pharmaceuticals: 2023 Annual Report Disclosure Prompt Notice
Erkang Pharmaceutical: Report of the Audit Committee on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Erkang Pharmaceuticals: 2023 Financial Results Report
Erkang Pharmaceutical: Notice on holding an online briefing on the 2023 annual results
Erkang Pharmaceuticals: Announcement on Accruing Credit and Asset Impairment Losses in 2023
Erkang Pharmaceutical: Announcement on the Company and Wholly-owned Subsidiaries Passing the New Certification of High-tech Enterprises
Erkang Pharmaceutical: Announcement on the completion of the sale of the third batch of shares of the 2020 Employee Stock Ownership Plan
Erkang Pharmaceutical: Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2023
Erkang Pharmaceutical: Legal Opinion of Hunan Qiyuan Law Firm on the Company\'s First Extraordinary General Meeting of Shareholders in 2023
Erkang Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2023
Erkang Pharmaceutical: Rules of Work of the Special Committee of the Board of Directors (November 2023)
Erkang Pharmaceutical: Comparative table of revisions to rules and regulations such as the “Articles of Association”
No Data
No Data